0.19
+0.0273(+16.78%)
Currency In USD
Previous Close | 0.16 |
Open | 0.26 |
Day High | 0.28 |
Day Low | 0.18 |
52-Week High | 22.08 |
52-Week Low | 0.12 |
Volume | 655.11M |
Average Volume | 27.26M |
Market Cap | 35.51M |
PE | 0 |
EPS | -80.39 |
Moving Average 50 Days | 0.15 |
Moving Average 200 Days | 3.69 |
Change | 0.03 |
If you invested $1000 in Tonix Pharmaceuticals Holding Corp. (TNXP) 10 years ago, it would be worth $0 as of November 21, 2024 at a share price of $0.19. Whereas If you bought $1000 worth of Tonix Pharmaceuticals Holding Corp. (TNXP) shares 5 years ago, it would be worth $0.02 as of November 21, 2024 at a share price of $0.19.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
GlobeNewswire Inc.
Nov 18, 2024 9:05 PM GMT
CHATHAM, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, announced toda
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
GlobeNewswire Inc.
Nov 18, 2024 12:00 PM GMT
Poster presentation highlighted results from confirmatory Phase 3 RESILIENT study of TNX-102 SL (sublingual cyclobenzaprine HCl) treatment demonstrating statistically significant improvement in primary endpoint of fibromyalgia nociplastic pain and in
Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
GlobeNewswire Inc.
Nov 13, 2024 9:05 PM GMT
CHATHAM, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announce